Evaluation of antimicrobial susceptibility testing methods for <i>Burkholderia cepacia</i> complex isolates from people with and without cystic fibrosis
Peter Jorth(California Institute of Technology), Holly Huse(UCLA Medical Center), Romney M. Humphries(Vanderbilt University Medical Center), Anna Clara Milesi Galdino(Universidade Federal do Rio de Janeiro), John J. LiPuma(University of Michigan), Daniel A. Green(Columbia University Irving Medical Center), Carmila Manuel(Vanderbilt University Medical Center), James E. A. Zlosnik(University of British Columbia), Maria M. Traczewski(Human BioMolecular Research Institute), Audrey N. Schuetz(Mayo Clinic), Maria Maldonado(UCLA Medical Center), Diana Celedonio(Cedars-Sinai Medical Center), Dennis Garica(UCLA Medical Center), Nicolynn C. Cole(Mayo Clinic)
Cited by 11
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections
|American Journal of Respiratory and Critical Care Medicine|2017|393
Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|391
Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders
|Nature Communications|2019|324
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
|INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|2009|317